drugset / Trial / NCT04804514
Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients
RandomizedSequentialDouble-blindTreatment
Summary
This is a phase 1/2a study in dentin hypersensitivity patients to assess the safety, tolerability, efficacy and pharmacokinetics of single and multiple doses of KH001.
Timeline
- Start
- 2021-06-14
- Primary completion
- 2023-03-03
- Completion
- 2023-03-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KH001 | Unknown | — | Other |